相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
Jocelyne Jacquemier et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
Aaron S. Mansfield et al.
BMC CANCER (2009)
Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways
Vivek Roy et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
IDO inhibits T-cell function through suppressing Vav1 expression and activation
Runmei Li et al.
CANCER BIOLOGY & THERAPY (2009)
Immune Manipulation of Advanced Breast Cancer: An Interpretative Model of the Relationship Between Immune System and Tumor Cell Biology
Andrea Nicolini et al.
MEDICINAL RESEARCH REVIEWS (2009)
Epithelial to mesenchymal transition and breast cancer
Eva Tomaskovic-Crook et al.
BREAST CANCER RESEARCH (2009)
Epithelial mesenchymal transition traits in human breast cancer cell lines
T. Blick et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab
Michel Marty et al.
EUROPEAN JOURNAL OF CANCER (2008)
EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy
Fernanda Milanezi et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
Sandra D. Bohling et al.
MODERN PATHOLOGY (2008)
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma
Rainer Riesenberg et al.
CLINICAL CANCER RESEARCH (2007)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer
Takafumi Nakamura et al.
CANCER SCIENCE (2007)
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
Antonio Curti et al.
BLOOD (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Vimentin and epithelial-mesenchymal transition in human breast cancer - Observations in vitro and in vivo
Maria I. Kokkinos et al.
CELLS TISSUES ORGANS (2007)
The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer
A. E. Roussidis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
K. Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO
Gargi D Basu et al.
JOURNAL OF IMMUNOLOGY (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism
O Takikawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Modulation of tryptophan catabolism by regulatory T cells
F Fallarino et al.
NATURE IMMUNOLOGY (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Tryptophan catabolism and regulation of adaptive immunity
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
GK Lee et al.
IMMUNOLOGY (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CD4+CD25+ regulatory cells in acquired MHC tolerance
EH Field et al.
IMMUNOLOGICAL REVIEWS (2001)
分享论文
